Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer remains a clinical challenge with considerable mortality. Circulating tumor DNA (ctDNA) has been suggested as a prognostic biomarker and enables the longitudinal evaluation of a patient’s disease and response to treatment. However, the role of ctDNA in treatment monito...

Descripción completa

Detalles Bibliográficos
Autores principales: Faaborg, Louise, Andersen, Rikke Fredslund, Waldstrøm, Marianne, Henriksen, Jon Røikjær, Adimi, Parvin, Jakobsen, Anders, Steffensen, Karina Dahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997085/
https://www.ncbi.nlm.nih.gov/pubmed/35406538
http://dx.doi.org/10.3390/cancers14071766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997085/
https://www.ncbi.nlm.nih.gov/pubmed/35406538
http://dx.doi.org/10.3390/cancers14071766

Ejemplares similares